HeartFlow touts expanded insurer coverage for FFRct analysis

HeartFlow today touted that seven new insurers released positive medical policies supporting coverage for its HeartFlow FFRct analysis following a coronary computed tomography angiogram, expanding coverage to a total of 185 million patients. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across coronary lesions. Positive medical policies were issued by Cigna, Florida Blue, Blue Cross and Blue Shield plans of Michigan, North Carolina and Vermont, Highmark Inc and Independence Blue Cross, HeartFlow said. “These positive coverage decisions reinforce the clinical and economic value of the HeartFlow Analysis in addressing how heart disease is diagnosed and treated. With the growing momentum of coverage, a wealth of scientific evidence, and unparalleled technology, the HeartFlow Analysis is poised to become the standard of care for patients with suspected heart disease,” prez &CEO Dr. John Stevens said in a press release. The new coverage decisions from commercial payers increase the amount of patients eligible for HeartFlow analysis up to 130 million, while 55 million Medicare beneficiaries are covered due to a recent New Technology APC payment decision from the Centers for Medicare &Medicaid Services. In December, HeartFlow took a $90 million step toward the $150 million it hoped ...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Cardiovascular HeartFlow Source Type: news

Related Links:

In the United Kingdom, around 56,000 patients with angina, a chest condition that can decrease blood flow to the heart, were unable to undergo necessary CT scans last year due to the region ’s radiologist shortage.According to a recent review from the Royal College of Radiologists (RCR) and the British Society of Cardiovascular Imaging (BSCI), there should have been 132,090 CT coronary angiography (CTCA) tests performed throughout England, Scotland, Wales, and Northern Ireland in 2017. However, only 75,791 —or 57 percent — of those tests were administered.Approximately 69,900 scans were performed in Engla...
Source: radRounds - Category: Radiology Authors: Source Type: blogs
Abstract OBJECTIVES:: To compare the ability of test scans with undiluted and diluted contrast medium (CM) to predict contrast enhancement (CE) on cardiovascular computed tomography angiography (CCTA) images of infants. METHODS:: We divided 120 consecutive infants who had undergone CCTA on a 64-MDCT scanner into two equal groups. In one group the test bolus consisted of undiluted CM [protocol 1 (P1): injection volume = total  body weight (TBW) × 1.2  ml, injection time 5  sec], in the other (P2) it was TBW × 4.0  ml (CM 15%, saline 85%, injection time 16  sec). C...
Source: The British Journal of Radiology - Category: Radiology Authors: Tags: Br J Radiol Source Type: research
Conclusions: These results support the assertion that NaF PET/CT is an effective imaging modality with respect to the detection and quantification of atherosclerotic plaque deposition of the coronary vasculature.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Tags: Advances In Imaging of Atherosclerosis Source Type: research
HeartFlow said today it closed a $240 million Series E round of financing, with funds slated to support commercial expansion and studies of its HeartFlow FFRct analysis system. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across coronary lesions. Financing in the round included investments from Wellington Management, Baillie Gifford &Company and existing investors, the company said. “We are delighted to be investing in HeartFlow on beha...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Funding Roundup HeartFlow Source Type: news
Abstract Pulmonary artery aneurysms (PAA) and pseudoaneurysms (PAP) are caused by infections, vasculitis, trauma, pulmonary hypertension, congenital heart disease, and connective tissue disease. Most cases of such aneurysm occur in the trunk or major branches of the pulmonary artery, while the peripheral type is less common. The treatment modalities are medical therapy, surgery, and percutaneous catheter embolization. The mortality rate associated with rupture is approximately 50%. We encountered a case of a 53-year-old man with a pulmonary artery pseudoaneurysm secondary to pneumonia and cavity formation during c...
Source: Annals of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Cardiovasc Surg Source Type: research
Publication date: Available online 10 January 2018 Source:Revista Española de Cardiología (English Edition) Author(s): Andreas A. Giannopoulos, Oliver Gaemperli Hybrid imaging for ischemic heart disease refers to the fusion of information from a single or usually from multiple cardiovascular imaging modalities enabling synergistic assessment of the presence, the extent, and the severity of coronary atherosclerotic disease along with the hemodynamic significance of lesions and/or with evaluation of the myocardial function. A combination of coronary computed tomography angiography with myocardial perfusion ima...
Source: Revista Espanola de Cardiologia - Category: Cardiology Source Type: research
Authors: Chaosuwannakit N Abstract Introduction: Primary evaluation of patients with congenital heart disease (CHD) traditionally relies on echocardiography and conventional cardiac angiography (CCA), both of which have potential limitations. Aim: To test the hypothesis that cardiac computed tomography angiography (CCTA) is useful in the diagnosis and management of these patients. Material and methods: The 3-year observational, analytical, retrospective, cohort study included a total of 111 tomographic studies of patients with congenital heart disease. Computed tomography scans were read twice and medical record...
Source: Polish Journal of Cardio-Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Tags: Kardiochir Torakochirurgia Pol Source Type: research
A 48-year-old male presented with symptomatic ventricular tachycardia of 226 b.p.m. After external cardioversion, electrocardiogram revealed a complete right bundle branch block but no other abnormalities. Echocardiography showed a reduced left ventricular-function (ejection fraction: 49%) with dyskinesia of the basal septum and anterior wall; however, coronary heart disease was excluded by angiography. On subsequent simultaneous positron emission tomography/magnetic resonance imaging (PET/MRI), a diffuse, band-shaped, mostly subendocardial late gadolinium enhancement was observed within both ventricles particularly within...
Source: European Heart Journal - Category: Cardiology Source Type: research
Publication date: Available online 27 October 2017 Source:Journal of Veterinary Cardiology Author(s): Lauren E. Markovic, Brian A. Scansen, Brianna M. Potter Two domestic shorthair cats, a 6-month-old castrated male and a 7-month-old intact female, were diagnosed with complex congenital heart disease. Transthoracic echocardiography in both cats revealed a dilated arterial trunk overriding the interventricular septum with a large ventricular septal defect. The pulmonary trunk and branch pulmonary arteries were not visible using standard echocardiographic views in either cat. The differential diagnosis for both cats include...
Source: Journal of Veterinary Cardiology - Category: Veterinary Research Source Type: research
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
More News: Angiography | Cardiology | Cardiovascular | CT Scan | Heart | Heart Disease | Insurers | Marketing | Medicaid | Medicare | PET Scan